In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run. Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FDA’s rejection of Lycos Therapeutics’ MDMA-assisted therapy ap...
All content for Divergent States is the property of Divergent States and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run. Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FDA’s rejection of Lycos Therapeutics’ MDMA-assisted therapy ap...
Rick Doblin Unplugged: Psychedelics, Parenting, Trauma & the Future of MAPS
Divergent States
1 hour 6 minutes
9 months ago
Rick Doblin Unplugged: Psychedelics, Parenting, Trauma & the Future of MAPS
In this episode of Divergent States, we sit down with Rick Doblin, founder of MAPS (Multidisciplinary Association for Psychedelic Studies), for a raw, unscripted conversation on the future of psychedelic therapy, the dangers of hype, and the deeply personal reasons behind his decades-long mission. We go deep into: Why MDMA was criminalized and how Doblin outmaneuvered the DEAThe hard lessons from MAPS' FDA rejection and what's nextParenting and psychedelics: how both Rick and 3L1T3 approach e...
Divergent States
In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run. Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FDA’s rejection of Lycos Therapeutics’ MDMA-assisted therapy ap...
